Therapeutic agents
US10118901B2 · kind B2 · utility
23Cited by
15References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2013 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Sep 22, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a class of hydroxamic acid compounds of Formula (I), which act as alkylating agents and/or inhibitors of the HDAC pathway, having potential utility in the treatment of a neoplastic disease and immune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.